Manulife IncomeSecure: A Regular-Premium Whole Life Plan with Cash Coupons

Manulife IncomeSecure is a regular-premium participating whole life insurance plan from Manulife (Singapore) Pte. Ltd., designed to provide a lifelong stream of income up to age 120. The policy allows policyholders to choose between a 5-year or 10-year premium payment term, with income payouts commencing at the end of policy year 3 (for 5-year payers), year 5, or year 10 (for 10-year payers). It combines guaranteed and non-guaranteed yearly income components, which can be received as cash coupons or accumulated at a prevailing interest rate. The plan also includes coverage for death, terminal illness, and a specific terminal cancer benefit, alongside a maturity benefit payable at age 120.

How it compares

To understand Manulife IncomeSecure’s position in the market, we compare it against three similar whole life income products using data from CompareFIRST.sg as of July 2026. The comparison basis is an age 35 male non-smoker, with premiums and surrender values normalized per $100,000 sum assured (SA).

Premium Costs Manulife IncomeSecure requires an annual premium ranging from $5,000 to $100,000, with an average of $38,209 across 254 quotes. In the peer comparison table, it is listed at a baseline of $10,000 per year for a 6-to-10-year premium term. This makes it significantly more expensive than Etiqa’s Enrich Income ($5,000/yr) and substantially cheaper than Prudential’s PRULifetime Income Plus RP ($25,000/yr). It is priced similarly to China Taiping’s i-CashLife, which also sits at $10,000/yr.

Surrender Value at Year 20 At the end of policy year 20, Manulife IncomeSecure shows a projected surrender value of $100,060 per $100k SA. This is lower than Etiqa Enrich Income ($101,100) and China Taiping i-CashLife ($101,510), but higher than Prudential PRULifetime Income Plus RP ($99,300). The illustrated surrender value for a $50,000 SA at year 20 is $50,060 (projected up to $50,560), indicating that the base guaranteed component grows slowly, while the total value relies heavily on non-guaranteed elements.

Returns and Expenses The Total Expense Ratio (TER) for Manulife IncomeSecure at year 5 is 2.40%, which is moderate compared to Etiqa’s 2.25% and Prudential’s 2.27%, but significantly lower than China Taiping’s i-CashLife (5.12%). The net investment return for the participating fund is 3.63% over 3 years, though 5-year and 10-year data are not available. In contrast, Prudential reports a 5-year net return of 2.23%, while Etiqa shows negative returns (-0.40%) at 5 years and 1.92% at 10 years. Manulife’s illustrated surrender yield ranges from 1.78% to 2.84% p.a., reflecting the conservative nature of its guaranteed components versus the potential upside of non-guaranteed bonuses.

Pros

• Flexible Income Options: Policyholders can choose to receive yearly income as cash coupons or accumulate them with interest, offering liquidity management flexibility.
• No Underwriting Required: The plan does not require medical underwriting, making it accessible for those who may have health concerns.
• Terminal Cancer Benefit: Offers a specific additional benefit (50% or 100% of annual premium) if diagnosed with terminal cancer before age 75, providing targeted support for this condition.
• Strong Insurer Rating: Backed by Manulife’s strong credit ratings (AA- from S&P and Fitch; A1 from Moody’s), ensuring financial stability.
• Cash Coupons: Allows policyholders to take a regular stream of income without needing to surrender the policy, preserving lifelong coverage.

Cons

• High Premiums: Compared to peers like Etiqa Enrich Income, the premium cost is double for similar coverage structures, which may impact affordability for some consumers.
• Limited Guaranteed Returns: The guaranteed yearly income is relatively low (0.759% – 0.800% of SA), meaning a significant portion of the returns depends on non-guaranteed bonuses, which are not assured.
• No SRS/CPFIS Payments: The plan does not allow payment via Supplementary Retirement Scheme (SRS) or CPF Investment Scheme (CPFIS) premiums, limiting tax-advantaged funding options for Singaporeans.
• Complex Payout Structures: The varying income payout years and premium terms can make it difficult to compare directly with simpler products without detailed illustrations.
• Exclusions: Terminal illness coverage excludes HIV-related conditions, and the terminal cancer benefit is limited to $200,000 across all policies.

Who it may suit

Manulife IncomeSecure may suit individuals seeking a stable, long-term income stream with minimal underwriting hurdles. It is particularly relevant for those who prioritize insurer strength (AA- rated) and want the option of cash coupons without surrendering their policy. However, due to the lack of SRS/CPFIS payment options and higher relative premiums, it may be less suitable for cost-sensitive buyers or those looking to leverage tax-deferred retirement savings schemes. Consumers should carefully weigh the reliance on non-guaranteed returns against the security of the guaranteed components.

This is general information based on CompareFIRST.sg data, not financial advice. Premiums and features can change; please verify with the insurer or a MAS-licensed financial adviser before making any decision.